Lv4
630 积分 2024-01-12 加入
Antibody engineering
13小时前
已完结
Designing stable humanized antibodies
2天前
已完结
P2.10.10 Soluble Ceacam5 Resistant ADC for Effective Tumor Targeted Delivery With Clinically Validated Tumor Selective Linker Payload
3天前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
11天前
已完结
Engineered human blood–brain barrier microfluidic model for vascular permeability analyses
25天前
已完结
FRα, B7-H4, and HER2 expression in endometrial cancer: Assessing the promise of antibody drug conjugate therapies
1个月前
已完结
Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1–positive advanced non–small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies
1个月前
已完结
Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity
1个月前
已完结
Bispecific antibody targeting both B7-H3 and PD-L1 exhibits superior antitumor activities
1个月前
已完结
Crossing the blood–brain barrier: emerging therapeutic strategies for neurological disease
1个月前
已完结
皖公网安备34019202002308
